查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088023

認知功能恢復解決方案市場預測至2034年－按解決方案類型、疾病類型、技術、應用、最終用戶和地區分類的全球分析

Cognitive Recovery Solutions Market Forecasts to 2034 - Global Analysis By Solution Type, Disorder Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球認知功能恢復解決方案市場預計將在 2026 年達到 125 億美元，並在預測期內以 10.2% 的複合年成長率成長，到 2034 年達到 273 億美元。

認知復健方案是指旨在恢復、復健和補償由神經損傷、神經退化性疾病或後天性腦損傷引起的認知障礙的專業治療技術和臨床干預措施。這些方案包括神經刺激設備、虛擬實境（VR）復健平台、數位治療應用以及針對特定認知領域（例如記憶力、注意力、語言能力和執行功能）的神經回饋系統。認知復健技術整合了患者特定的評估數據、自適應訓練演算法和後續觀察工具，以實現復健方案的個人化。這些方案是針對尋求實證認知復健的醫院、復健中心、神經科診所和長期照護機構。

中風和創傷性腦損傷的盛行率

全球中風和創傷性腦損傷發病率的持續上升，顯著推動了認知復健解決方案市場的需求。根據世界卒中組織統計，全球每年約有1500萬例中風病例，其中許多病例伴隨嚴重的認知障礙，影響復健效果。交通事故和跌倒是創傷性腦損傷發生率上升的重要因素，尤其是在人口老化和發展中地區。在醫療保健系統中，認知復健日益被視為急性後期照護路徑的重要組成部分。保險報銷機制的完善也擴大了基於神經技術的認知復健介入措施的應用範圍。

還款限制

認知復健技術保險報銷範圍的不統一性和有限性，對「認知功能恢復解決方案市場」的准入構成重大障礙。許多保險公司將數位化認知訓練和神經回饋歸類為「實驗性」或「研究性」療法，而非標準治療。缺乏統一的技術驅動型認知復健計費代碼，也使醫療服務提供者的保險報銷流程變得複雜。長期療效研究雖然能證明其成本效益，但不足以說服保守的保險公司。患者自費承擔的干預費用也限制了目標市場的滲透。

居家康復

朝向居家與遠距認知復健模式的轉變，為認知復健解決方案市場帶來了變革性的機會。遠端保健期間，遠端醫療保險覆蓋範圍的擴大，為遠端醫療監測樹立了監管先例。居家神經刺激和數位化治療平台突破了門診就診的限制，實現了持續康復。整合了看護者功能的系統為家庭提供培訓和監測工具，以支持患者復原。臨床基礎設施需求的降低，擴大了服務覆蓋範圍，惠及服務不足的地區。

使用藥物的替代療法

針對阿茲海默症和其他神經退化性疾病的緩解疾病療法的開發平臺對認知復健解決方案的市場地位構成了競爭威脅。 FDA批准的針對澱粉樣蛋白病變的單株抗體療法可能會降低人們對補償認知復健方法的重視程度。製藥公司的行銷預算遠遠超出其在神經技術認知方面的投入。臨床醫生在處方傾向中可能會優先考慮藥物治療而非基於技術的復健治療。

新冠疫情的影響：

新冠疫情擾亂了線下復健服務，同時加速了遠端醫療和遠距認知療法的普及。醫院容量的限制延緩了部分復健計畫的啟動。然而，疫情提高了人們對新冠患者在急性期後可能出現的認知後遺症（例如「腦霧」和注意力缺陷）的認知。疫情後的醫療體系將繼續投資於混合復健模式，將遠距數位平台與常規臨床評估結合。

在預測期內，神經刺激設備細分市場預計將佔據最大的市場佔有率。

在預測期內，神經刺激設備預計將佔據最大的市場佔有率。這主要歸功於經顱磁刺激 (TMS) 和直流刺激 (DC) 系統已確立的臨床療效、法規核准以及較高的單次治療收入。目前，神經刺激設備在醫院和診所的認知復健介入支出中佔據了絕大部分。 FDA 對憂鬱症和強迫症適應症的批准流程為擴大認知功能應用範圍的報銷樹立了先例。設備製造商正在繼續進行廣泛的臨床試驗項目，以支持其療效聲明。

預計在預測期內，阿茲海默症細分市場將呈現最高的複合年成長率。

在預測期內，阿茲海默症領域預計將呈現最高的成長率，這主要受前所未有的全球人口結構變化以及由此導致的失智症盛行率激增的影響，而這些患者需要認知干預。多種緩解疾病藥物臨床試驗的失敗正促使研究投資轉向非藥物認知復健方法。針對記憶和執行功能的數位治療平台已展現出令人鼓舞的臨床試驗結果。醫療保險公司也日益認知到預防性認知介入的成本效益。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的神經復健基礎設施、完善的保險覆蓋體係以及在研發領域的巨額投入。美國擁有全球最大的經認證的腦損傷復健機構網路。加拿大擁有先進的醫療保健政策，支持患者獲得技術驅動的復健服務。主要的神經技術製造商的總部和臨床試驗中心均設在北美。該地區的學術醫療中心引領全球認知復健研究。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要歸因於該地區龐大的中風和創傷性腦損傷病例數、政府為推進醫療現代化所做的努力以及對神經康復基礎設施投入的增加。中國正透過一項全國性的康復擴容計畫來應對全球最嚴重的中風負擔。日本正利用科技整合的照護模式來應對老齡化人口中日益成長的失智症盛行率。印度和東南亞國家正在發展神經復健系統，以滿足創傷和中風患者日益成長的復原需求。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球認知功能復原解決方案市場：依解決方案類型分類

  • 認知復健軟體
  • 神經刺激設備
  • 數位療法
  • 神經回饋系統
  • 恢復監控平台
  • 認知功能評估工具
  • 綜合復健計劃

第6章 全球認知功能恢復解決方案市場：依疾病類型分類

  • 創傷性腦損傷
  • 中風復健
  • 阿茲海默症
  • 失智症
  • 帕金森氏症
  • 腦震盪後遺症
  • 其他認知障礙

第7章 全球認知功能恢復解決方案市場：依技術分類

  • 人工智慧
  • 虛擬實境
  • 擴增實境
  • 腦機介面
  • 腦電圖分析
  • 基於雲端的平台

第8章 全球認知功能恢復解決方案市場：按應用分類

  • 恢復
  • 注意力恢復
  • 言語復健
  • 運動和認知復健
  • 恢復執行功能
  • 行為療法支持

第9章 全球認知功能恢復解決方案市場：按最終用戶分類

  • 醫院
  • 復健中心
  • 神經科診所
  • 長期照護機構
  • 家庭醫療保健服務提供者
  • 研究機構

第10章 全球認知功能復原解決方案市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Medtronic plc
  • BrainsWay Ltd.
  • NeuroPace, Inc.
  • Abbott Laboratories
  • Neuroelectrics
  • Ceribell Inc.
  • Natus Medical Incorporated
  • Posit Science Corporation
  • Cognifit Ltd.
  • Philips Healthcare
  • Compumedics Limited
  • BrainCo Inc.
  • Blackrock Neurotech
  • Kernel Inc.
  • Pear Therapeutics
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
Product Code: SMRC37919

According to Stratistics MRC, the Global Cognitive Recovery Solutions Market is accounted for $12.5 billion in 2026 and is expected to reach $27.3 billion by 2034 growing at a CAGR of 10.2% during the forecast period. Cognitive recovery solutions refer to specialized therapeutic technologies and clinical interventions designed to restore, rehabilitate, and compensate for cognitive function impairments resulting from neurological injury, neurodegenerative disease, or acquired brain damage. These solutions encompass neurostimulation devices, virtual reality rehabilitation platforms, digital therapeutic applications, and neurofeedback systems that target specific cognitive domains, including memory, attention, language, and executive function. Cognitive recovery technology integrates patient-specific assessment data, adaptive training algorithms, and progress monitoring tools to personalize rehabilitation protocols. The solutions serve hospitals, rehabilitation centers, neurology clinics, and long-term care facilities seeking evidence-based cognitive restoration.

Market Dynamics:

Driver:

Stroke and TBI prevalence

The escalating global incidence of stroke and traumatic brain injury is driving substantial demand for Cognitive Recovery Solutions Market interventions. The World Stroke Organization reports fifteen million stroke cases annually worldwide with significant cognitive sequelae affecting recovery outcomes. Road traffic accidents and falls contribute to rising traumatic brain injury rates particularly in aging populations and developing regions. Healthcare systems increasingly prioritize cognitive rehabilitation as essential components of post-acute care pathways. Insurance reimbursement frameworks are expanding coverage for neurotechnology-based cognitive recovery interventions.

Restraint:

Reimbursement limitations

The inconsistent and limited reimbursement coverage for cognitive rehabilitation technologies presents significant market access barriers for the Cognitive Recovery Solutions Market. Many payers classify digital cognitive training and neurofeedback as experimental or investigational rather than standard of care. The absence of uniform billing codes for technology-enabled cognitive rehabilitation complicates provider reimbursement. Long-term outcome studies demonstrating cost-effectiveness are insufficient to persuade conservative payer organizations. Patient out-of-pocket costs for uncovered interventions limit addressable market penetration.

Opportunity:

Home-based rehabilitation

The transition toward home-based and remote cognitive rehabilitation models presents transformative opportunities for the Cognitive Recovery Solutions Market. Telehealth reimbursement expansions during the pandemic established regulatory precedents for remote therapeutic monitoring. Home-based neurostimulation and digital therapeutic platforms enable continuous rehabilitation beyond clinic visit constraints. Caregiver-integrated systems provide family members with training and oversight tools for supporting patient recovery. The reduction in clinical infrastructure requirements expands service accessibility to underserved geographic regions.

Threat:

Pharmaceutical alternatives

The advancing pipeline of disease-modifying pharmaceutical therapies for Alzheimer's disease and other neurodegenerative conditions poses a competitive threat to Cognitive Recovery Solutions Market positioning. FDA-approved monoclonal antibody therapies targeting amyloid pathology may reduce emphasis on compensatory cognitive rehabilitation approaches. Pharmaceutical marketing budgets substantially exceed neurotechnology education investments. Clinician prescribing habits may prioritize pharmacological interventions over technology-based rehabilitation.

Covid-19 Impact:

The COVID-19 pandemic disrupted in-person rehabilitation services while accelerating telehealth and remote cognitive therapy adoption. Hospital capacity constraints delayed elective rehabilitation program initiations. However, the pandemic heightened recognition of cognitive sequelae, including brain fog and attention deficits in post-acute COVID patients. Post-pandemic healthcare systems continue investing in hybrid rehabilitation models combining remote digital platforms with periodic clinical assessment.

The neurostimulation devices segment is expected to be the largest during the forecast period

The neurostimulation devices segment is expected to account for the largest market share during the forecast period, due to the established clinical efficacy, regulatory clearances, and high per-procedure revenue associated with transcranial magnetic stimulation and direct current stimulation systems. Neurostimulation devices dominate current cognitive recovery intervention spending across hospital and clinic settings. The FDA clearance pathway for depression and obsessive-compulsive disorder indications creates reimbursement precedents for expanding cognitive applications. Device manufacturers maintain extensive clinical trial programs supporting efficacy claims.

The alzheimer's disease segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the alzheimer's disease segment is predicted to witness the highest growth rate, driven by the unprecedented global demographic shift and the corresponding surge in dementia prevalence requiring cognitive intervention. The failure of multiple pharmaceutical disease-modifying trials has redirected research investment toward non-pharmacological cognitive rehabilitation approaches. Digital therapeutic platforms targeting memory and executive function demonstrate promising clinical trial results. Healthcare payers increasingly recognize the cost-effectiveness of preventive cognitive interventions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the advanced neurorehabilitation infrastructure, comprehensive insurance coverage frameworks, and substantial research and development investment. The United States operates the largest network of certified brain injury rehabilitation facilities. Canada implements progressive healthcare policies supporting technology-enabled rehabilitation access. Major neurotechnology manufacturers maintain North American headquarters and clinical operations. The region's academic medical centers lead global cognitive recovery research.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to massive stroke and traumatic brain injury patient volumes, government healthcare modernization initiatives, and expanding neurorehabilitation infrastructure investment. China addresses the world's largest stroke burden with national rehabilitation expansion programs. Japan confronts aging-related dementia prevalence with technology-integrated care models. India and Southeast Asian nations develop neurorehabilitation capacity to address growing injury and stroke rehabilitation needs.

Key players in the market

Some of the key players in Cognitive Recovery Solutions Market include Medtronic plc, BrainsWay Ltd., NeuroPace, Inc., Abbott Laboratories, Neuroelectrics, Ceribell Inc., Natus Medical Incorporated, Posit Science Corporation, Cognifit Ltd., Philips Healthcare, Compumedics Limited, BrainCo Inc., Blackrock Neurotech, Kernel Inc., Pear Therapeutics, Siemens Healthineers AG and GE HealthCare Technologies Inc.

Key Developments:

In June 2026, Medtronic plc launched a next-generation closed-loop neurostimulation system for cognitive recovery following traumatic brain injury, featuring adaptive parameter optimization that continuously adjusts therapy delivery to enhance neurological rehabilitation outcomes and patient recovery trajectories.

In May 2026, Siemens Healthineers AG expanded its neuroimaging-guided rehabilitation platform by integrating real-time functional MRI feedback with cognitive training protocols, enabling clinicians to personalize treatment strategies and improve cognitive restoration effectiveness across diverse patient populations.

In April 2026, Abbott Laboratories partnered with a leading stroke rehabilitation network to deploy remote cognitive monitoring solutions across fifty post-acute care facilities, supporting continuous patient assessment, rehabilitation tracking, and data-driven therapeutic interventions for recovery optimization.

Solution Types Covered:

  • Cognitive Rehabilitation Software
  • Neurostimulation Devices
  • Digital Therapeutics
  • Neurofeedback Systems
  • Recovery Monitoring Platforms
  • Cognitive Assessment Tools
  • Integrated Rehabilitation Programs

Disorder Types Covered:

  • Traumatic Brain Injury
  • Stroke Recovery
  • Alzheimer's Disease
  • Dementia
  • Parkinson's Disease
  • Post-Concussion Syndrome
  • Other Cognitive Disorders

Technologies Covered:

  • Artificial Intelligence
  • Virtual Reality
  • Augmented Reality
  • Brain-Computer Interface
  • EEG Analytics
  • Cloud-Based Platforms

Applications Covered:

  • Memory Recovery
  • Attention Restoration
  • Language Rehabilitation
  • Motor-Cognitive Rehabilitation
  • Executive Function Recovery
  • Behavioral Therapy Support

End Users Covered:

  • Hospitals
  • Rehabilitation Centers
  • Neurology Clinics
  • Long-Term Care Facilities
  • Home Healthcare Providers
  • Research Institutes

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Cognitive Recovery Solutions Market, By Solution Type

  • 5.1 Cognitive Rehabilitation Software
  • 5.2 Neurostimulation Devices
  • 5.3 Digital Therapeutics
  • 5.4 Neurofeedback Systems
  • 5.5 Recovery Monitoring Platforms
  • 5.6 Cognitive Assessment Tools
  • 5.7 Integrated Rehabilitation Programs

6 Global Cognitive Recovery Solutions Market, By Disorder Type

  • 6.1 Traumatic Brain Injury
  • 6.2 Stroke Recovery
  • 6.3 Alzheimer's Disease
  • 6.4 Dementia
  • 6.5 Parkinson's Disease
  • 6.6 Post-Concussion Syndrome
  • 6.7 Other Cognitive Disorders

7 Global Cognitive Recovery Solutions Market, By Technology

  • 7.1 Artificial Intelligence
  • 7.2 Virtual Reality
  • 7.3 Augmented Reality
  • 7.4 Brain-Computer Interface
  • 7.5 EEG Analytics
  • 7.6 Cloud-Based Platforms

8 Global Cognitive Recovery Solutions Market, By Application

  • 8.1 Memory Recovery
  • 8.2 Attention Restoration
  • 8.3 Language Rehabilitation
  • 8.4 Motor-Cognitive Rehabilitation
  • 8.5 Executive Function Recovery
  • 8.6 Behavioral Therapy Support

9 Global Cognitive Recovery Solutions Market, By End User

  • 9.1 Hospitals
  • 9.2 Rehabilitation Centers
  • 9.3 Neurology Clinics
  • 9.4 Long-Term Care Facilities
  • 9.5 Home Healthcare Providers
  • 9.6 Research Institutes

10 Global Cognitive Recovery Solutions Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Medtronic plc
  • 13.2 BrainsWay Ltd.
  • 13.3 NeuroPace, Inc.
  • 13.4 Abbott Laboratories
  • 13.5 Neuroelectrics
  • 13.6 Ceribell Inc.
  • 13.7 Natus Medical Incorporated
  • 13.8 Posit Science Corporation
  • 13.9 Cognifit Ltd.
  • 13.10 Philips Healthcare
  • 13.11 Compumedics Limited
  • 13.12 BrainCo Inc.
  • 13.13 Blackrock Neurotech
  • 13.14 Kernel Inc.
  • 13.15 Pear Therapeutics
  • 13.16 Siemens Healthineers AG
  • 13.17 GE HealthCare Technologies Inc.

List of Tables

  • Table 1 Global Cognitive Recovery Solutions Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Cognitive Recovery Solutions Market Outlook, By Solution Type (2023-2034) ($MN)
  • Table 3 Global Cognitive Recovery Solutions Market Outlook, By Cognitive Rehabilitation Software (2023-2034) ($MN)
  • Table 4 Global Cognitive Recovery Solutions Market Outlook, By Neurostimulation Devices (2023-2034) ($MN)
  • Table 5 Global Cognitive Recovery Solutions Market Outlook, By Digital Therapeutics (2023-2034) ($MN)
  • Table 6 Global Cognitive Recovery Solutions Market Outlook, By Neurofeedback Systems (2023-2034) ($MN)
  • Table 7 Global Cognitive Recovery Solutions Market Outlook, By Recovery Monitoring Platforms (2023-2034) ($MN)
  • Table 8 Global Cognitive Recovery Solutions Market Outlook, By Cognitive Assessment Tools (2023-2034) ($MN)
  • Table 9 Global Cognitive Recovery Solutions Market Outlook, By Integrated Rehabilitation Programs (2023-2034) ($MN)
  • Table 10 Global Cognitive Recovery Solutions Market Outlook, By Disorder Type (2023-2034) ($MN)
  • Table 11 Global Cognitive Recovery Solutions Market Outlook, By Traumatic Brain Injury (2023-2034) ($MN)
  • Table 12 Global Cognitive Recovery Solutions Market Outlook, By Stroke Recovery (2023-2034) ($MN)
  • Table 13 Global Cognitive Recovery Solutions Market Outlook, By Alzheimer's Disease (2023-2034) ($MN)
  • Table 14 Global Cognitive Recovery Solutions Market Outlook, By Dementia (2023-2034) ($MN)
  • Table 15 Global Cognitive Recovery Solutions Market Outlook, By Parkinson's Disease (2023-2034) ($MN)
  • Table 16 Global Cognitive Recovery Solutions Market Outlook, By Post-Concussion Syndrome (2023-2034) ($MN)
  • Table 17 Global Cognitive Recovery Solutions Market Outlook, By Other Cognitive Disorders (2023-2034) ($MN)
  • Table 18 Global Cognitive Recovery Solutions Market Outlook, By Technology (2023-2034) ($MN)
  • Table 19 Global Cognitive Recovery Solutions Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
  • Table 20 Global Cognitive Recovery Solutions Market Outlook, By Virtual Reality (2023-2034) ($MN)
  • Table 21 Global Cognitive Recovery Solutions Market Outlook, By Augmented Reality (2023-2034) ($MN)
  • Table 22 Global Cognitive Recovery Solutions Market Outlook, By Brain-Computer Interface (2023-2034) ($MN)
  • Table 23 Global Cognitive Recovery Solutions Market Outlook, By EEG Analytics (2023-2034) ($MN)
  • Table 24 Global Cognitive Recovery Solutions Market Outlook, By Cloud-Based Platforms (2023-2034) ($MN)
  • Table 25 Global Cognitive Recovery Solutions Market Outlook, By Application (2023-2034) ($MN)
  • Table 26 Global Cognitive Recovery Solutions Market Outlook, By Memory Recovery (2023-2034) ($MN)
  • Table 27 Global Cognitive Recovery Solutions Market Outlook, By Attention Restoration (2023-2034) ($MN)
  • Table 28 Global Cognitive Recovery Solutions Market Outlook, By Language Rehabilitation (2023-2034) ($MN)
  • Table 29 Global Cognitive Recovery Solutions Market Outlook, By Motor-Cognitive Rehabilitation (2023-2034) ($MN)
  • Table 30 Global Cognitive Recovery Solutions Market Outlook, By Executive Function Recovery (2023-2034) ($MN)
  • Table 31 Global Cognitive Recovery Solutions Market Outlook, By Behavioral Therapy Support (2023-2034) ($MN)
  • Table 32 Global Cognitive Recovery Solutions Market Outlook, By End User (2023-2034) ($MN)
  • Table 33 Global Cognitive Recovery Solutions Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 34 Global Cognitive Recovery Solutions Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 35 Global Cognitive Recovery Solutions Market Outlook, By Neurology Clinics (2023-2034) ($MN)
  • Table 36 Global Cognitive Recovery Solutions Market Outlook, By Long-Term Care Facilities (2023-2034) ($MN)
  • Table 37 Global Cognitive Recovery Solutions Market Outlook, By Home Healthcare Providers (2023-2034) ($MN)
  • Table 38 Global Cognitive Recovery Solutions Market Outlook, By Research Institutes (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.